StockDuty ← Dashboard Oct 20, 2026 04:08 AM ET
SignalCorporate

Novo Nordisk, Eli Lilly Report GLP-1 Signals of Slowed Biological Aging at ARDD

Novo Nordisk and Eli Lilly report GLP-1 signals of slowed biological aging at ARDD.

What happened: Novo Nordisk and Eli Lilly reported GLP-1 signals of slowed biological aging at ARDD, per a MedPath trial news article. Why it matters: The report links the companies' GLP-1 drugs to aging-related findings presented at the ARDD event. Key numbers: Hacker News post: 4 points, 1 comment.
Novo Nordisk and Eli Lilly reported GLP-1 signals of slowed biological aging at ARDD, per a MedPath trial news article.
The report links the companies' GLP-1 drugs to aging-related findings presented at the ARDD event. Key numbers: Hacker News post: 4 points, 1 comment.
Sources